Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia

NCT01114126 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Neu-P11
DRUG: Neu-P11 placebo

Sponsor

Neurim Pharmaceuticals Ltd.